Using a two-stage discounted cash flow model, analysts estimate Stryker’s intrinsic value at around $318 per share. This ...

Treace Medical Concepts' slower growth, losses, and competition raise investment risks despite innovative tech. Read more ...

Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results. The webcast can be accessed at Stryker - Events & Presentations. An archive of the ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Several spine and orthopedic medtech companies announced new leadership moves in the first quarter of 2025. 1. Medtronic ...

Investment firm Viscogliosi Brothers completed its acquisition of Stryker’s U.S. spine business, according to an April 1 news ...

Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 ...

Stryker’s stock slipped 3.8% despite a strong fourth quarter, showing Wall Street can be squeamish even with stellar surgery.

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

From acquisitions and new leadership, here are six key updates from spine and orthopedic device companies since March 26: 1.

In Forbes‘ World’s Billionaires list, released April 1, highlights the world’s wealthiest individuals. Below is a breakdown ...

When Susan Stryker gives lectures around the country, she often starts with the same sentence: “Thank you for inviting me ...